中文 | English
Return
Total: 3 , 1/1
Show Home Prev Next End page: GO
Author:(Yixiu ZHAO)

1.The novel anthraquinone compound Kanglexin prevents endothelial-to-mesenchymal transition in atherosclerosis by activating FGFR1 and suppressing integrin β1/TGFβ signaling.

Yixiu ZHAO ; Zhiqi WANG ; Jing REN ; Huan CHEN ; Jia ZHU ; Yue ZHANG ; Jiangfei ZHENG ; Shifeng CAO ; Yanxi LI ; Xue LIU ; Na AN ; Tao BAN ; Baofeng YANG ; Yan ZHANG

Frontiers of Medicine 2024;18(6):1068-1086

2.Study on Sulfated Modification and Anti-psoriasis Activity of Polysaccharide from Dictamnus dasycarpus

Kai ZHANG ; Yu ZHANG ; Lihong WANG ; Yixiu ZHANG ; Yuliang WANG ; Tongchao ZHAO ; Hong ZHAO ; Ruirui WANG

China Pharmacy 2019;30(8):1049-1056

3.Prenatal Sonographic Diagnosis and Systematic Evaluation of Cardiac Rhabdomyoma

Yunshu OUYANG ; Yixiu ZHANG ; Hua MENG ; Xining WU ; Yuxin JIANG ; Qing DAI ; Qingwei QI ; Dachun ZHAO

Acta Academiae Medicinae Sinicae 2018;40(1):72-77

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3 , 1/1 Show Home Prev Next End page: GO